Edormiz tablets 50mg

Edormiz tablets 50mg (Anamorelin hydrochloride), manufactured by Ono Pharmaceutical (YJ code: 3999054F1028, standard: 50mg 1 tablet), is an orally active ghrelin receptor agonist. It is developed and used for the treatment of cancer cachexia and anorexia, particularly in patients with non-small cell lung cancer, aiming to improve appetite and increase body and lean body mass.